2026 Day 1 AgendaMonday, 27 April 2026 - ET (Eastern Time, GMT-05:00)

• New ideas and solutions to investigator challenges
• Practical tools and tips for handling difficult investigations and joint working with Legal/HR
• How are investigation outcomes shared with the organization?
• Providing clear, C-suite-endorsed messaging that encourages internal reporting
• Strengthening internal complaint pathways in addition to anonymous reporting options
• Approaches for responding to hotline reporters

• The importance of documenting your compliance program: practical dos and don’ts
• Does your documentation hold up to potential scrutiny such as litigation?
• Interplay between legal and compliance
• What needs to be privileged? Is privilege compliance documentation a help or hinderance when protecting company against litigation and where is the line?

• Understanding the different types of Board opportunities and positions and what is required for each
• Overview of HHS-OIG’s expectations and recommendations for Board oversight of ethics and compliance
• Essential competencies: critical skills and experiences that help compliance leaders transition to board service
• Writing your Board resume: understanding elements will help you stand out
• Building your board profile: developing the visibility, network, and credentials that open boardroom doors
• Tools and tips for running a compliance committee that align with HHS-OIG Guidance

• Scope of your compliance – what sits at the core of a compliance program?
• Evaluating current team capabilities against future skill requirements
• Skills needed for your program: considering outsourcing, offshoring, automation, local workforce etc
• Technical solutions: to what extent can automation help?
• Upskilling your workforce: considering the traditional background skills for compliance, what new skill sets do you need to instill or seek out?
• Managing prioritization for new skills: Compliance manager vs data scientist – how do you sell benefits between one or another?

• Interpreting the latest EO and DOJ guidance impacting R&D
• Examining HCP interactions under R&D
• Examining risk exposure and approaches to designing policies to mitigate risk

• Common trip points and cross-functional working

• How to clearly define the difference between Legal, Compliance, and Regulatory risk

• How are you tying the different elements of your compliance program together?
• Who and how to measure the effectiveness of your Compliance program
• How do you then identify what is driving lower scores so that you can effectively manage that particular risk?
• Evidencing continual growth to your Executives and Board

• Tools to simplify your risk assessments, focus on what truly matters, and leverage them as a powerful driver of Compliance

• How to adapt your risk assessment approach based on company size, pre-commercial or commercial, and aligned with your operational realities

• From paper to practice: turning risk assessments into action plans

• Practical tips to get the most value from your risk assessment process

• Benchmarking risks to track progress and trends over time

This private gathering is designed exclusively for the most senior Compliance leaders, offering a unique opportunity to share insights, foster meaningful peer connections, and engage in advanced programming tailored to the evolving challenges of top Compliance leadership.

Key Features:

• Confidential Peer Discussions: Engage in open and secure conversations with fellow leaders
• Leadership-Focused Discussion: Participate in sessions designed to address strategic leadership challenges
• Forward-Thinking Insights: Explore innovative approaches and future trends in leadership